CACrown ArchivesThe cinema collection
EN/FR
Search
Menu
Research dossier · Science & Nature

Zelandopam

chemical compound

Specimen drawers, botanical folios and brass scientific instruments under study light
Science and natureInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionJun 4, 2026
Entity authorityQ27280859 ↗
Source-derived summary

Zelandopam (INNTooltip International Nonproprietary Name; developmental code names YM-435, MYD-37) is a selective dopamine D1-like receptor agonist related to fenoldopam which was under development in Japan for the treatment of hypertension and heart failure but was never marketed. The drug was being developed for use by intravenous administration. The development of zelandopam appears to have been discontinued by the early 2000s. It was first described in the scientific literature by 1991.

Editorial summary

“Zelandopam” enters the record as chemical compound. Crown Archives preserves that source wording while asking what Zelandopam, chemical and compound can confirm, complicate or overturn.

Editorial reviewUseful for establishing the present vocabulary of the subject while preserving a route back to the evidence on which that vocabulary rests. The current lead gives the account dated anchors—1991—that can be checked directly. The selected authority fields contribute no independent date. Its strongest next move is a source search built around Zelandopam, chemical and compound.
Editorial analysis

Why this record matters

“Zelandopam” is worth following because a concise public description often conceals a longer documentary argument. Here, Zelandopam, chemical and compound provides the most credible route into that argument.

Evidence profile

Datasets, specimens, observations and peer-reviewed methods provide the appropriate test for the technical claims summarized here. The source revision retrieved here is dated Jun 4, 2026. The linked authority identifier is Q27280859. None of the 0 selected statements returned an explicit reference. The first chronological checks are 1991.

Critical limits

Scientific names, classifications and consensus can change while older terminology persists in catalogues and historical literature. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Check terminology, classification and the date of the cited evidence. Scientific names and technical consensus can change while older records retain historical value.

Best used for
  • Current terminology
  • Classification context
  • Finding cited technical literature
Verify next

Primary datasets, specimen catalogues, standards bodies and the most recent peer-reviewed literature.

Three-step research path

  1. Establish the record: confirm the title “Zelandopam”, its source revision and the description used here.
  2. Expand the search: follow Zelandopam primary sources, Zelandopam archive and Zelandopam research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “Zelandopam”?
  2. Is the terminology current, historical or disputed?
  3. Has classification or technical consensus changed since the cited source?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from “Zelandopam” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.